APA (7th ed.) Citation

JH, K., AE, R., AA, S., R, H., AE, F., CM, F., . . . JT, C. (2021). Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update. Clinical pharmacology and therapeutics, 109(2), 302. https://doi.org/10.1002/cpt.2008

Chicago Style (17th ed.) Citation

JH, Karnes, et al. "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update." Clinical Pharmacology and Therapeutics 109, no. 2 (2021): 302. https://doi.org/10.1002/cpt.2008.

MLA (9th ed.) Citation

JH, Karnes, et al. "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update." Clinical Pharmacology and Therapeutics, vol. 109, no. 2, 2021, p. 302, https://doi.org/10.1002/cpt.2008.